| |
|
|
|
Tracon Pharma
|
|
2.1999 -0.0001 (-0.0046%) |
8/21/2017 3:31pm |
|
Open: |
2.2000 |
Pre close: |
2.2000 |
Target:
|
2.66
|
|
High: |
2.2000 |
Low: |
2.1750 |
Resistance:
|
2.28
2.45
|
|
Volume: |
8,719 |
Market Cap: |
36.64M |
Support:
|
2.00
1.66
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.19
 |
MACD |
MACD(12,26):
|
-0.03  |
|
MA(20): |
2.22 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.78 |
Stochastic Oscillator |
%K(14,3):
|
42.19 |
|
MA(250): |
4.29 |
%D(3): |
37.06 |
|
Average Volume(K) |
3-Month: |
5080
|
52-Week |
High:
|
7.30 |
|
10-Days: |
592 |
Low: |
2.00 |
|
RSI |
RSI(14):
|
46.51 |
Change(%): |
-66.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.020 |
Return on Equity (ttm) |
-146.4 |
Shares Out. (M) |
16.61 |
|
EPS Est. Current Year |
-1.800 |
Return on Assets (ttm) |
-44.0 |
Shares Float (M) |
9.24 |
|
EPS Est. Next Year |
-1.860 |
PEG Ratio |
0.00 |
% Held by Insiders |
37.69 |
|
EPS Est. Next Quarter |
-0.470 |
Qtrly Rev. Growth |
-21.8 |
% Held by Institutions |
36.10 |
|
Forward EPS |
-1.864 |
Gross Profit (p.s.) |
0.208 |
Shares Short (K) |
325 |
|
Book Value (p.s.) |
1.390 |
EBITDA (p.s.) |
-1.495 |
P/E |
-1.09 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.58 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.30 |
P/S |
203001872.00 |
|
Operating Margin |
-926.81 |
Levered Free Cash Flow
(M) |
-14.12 |
P/CF |
-1.57 |
|
|
|
|
|
|
|
